Compare drug alternatives
® Alternatives
®() | Takhzyro®(Lanadelumab-Flyo) |
|---|---|
Prescription Only | Prescription Only |
| Dosage & Administration | Dosage & Administration comparison data |
Administration | |
Subcutaneous. Learn more. | |
Dosing | |
Adult and pediatric patients 12 years of age and older: administer 300 mg every 2 weeks. 6 to less than 12 years of age: administer 150 mg every 2 weeks. Pediatric patients 2 to less than 6 years of age: administer 150 mg every 4 weeks.. Learn more. | |
Latin Shorthand | |
Adult and pediatric patients (≥12 years): 300 mg every 2 weeks. Patients aged 6 to <12 years: 150 mg every 2 weeks. Patients aged 2 to <6 years: 150 mg every 4 weeks.. Learn more. | |
| Financial Assistance | Financial Assistance comparison data |
Out-Of-Pocket Costs With Copay Card | |
$0. Learn more. | |
Annual Cap | |
Assistance Expiration | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
| Physician Advisory | Physician Advisory comparison data |
Adverse Reactions | |
The most common adverse reactions (≥10%) are injection site
reactions, upper respiratory infections, headache, rash, dizziness,
diarrhea, and myalgia.. Learn more. | |
Mechanism of Actions (MoA) | |
Drugs used in Hereditary Angioedema. Learn more. | |
Special Populations | |